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for nuclear transport receptor binding, a cyclophilin ho-A New Clue at the Nuclear Pore:
mology region, and other potentially functional domainsRanBP2 Is an E3 Enzyme for SUMO1 (Yokoyama et al., 1995; see Figure, panel A). A region
of this protein that was originally termed the IR domain
(Yokoyama et al., 1995) is the site of RanGAP1 binding
(Matunis et al., 1998) and also associates strongly withA recent paper in Cell shows that the large nucleoporin
the E2 enzyme for SUMO1, Ubc9 (Saitoh et al., 1998).RanBP2 can act as an E3 enzyme for the ubiquitin-
This region of RanBP2 can be modified by conjugationlike protein SUMO1. These intriguing results raise im-
to SUMO1 (Saitoh et al., 1998).portant questions about the mechanism of SUMO1
Pichler et al. (2002) found that the IR domain not onlyconjugation, the relationship of SUMO1 to nuclear
became modified in in vitro assays containing SUMO1transport, and the regulation of RanBP2 in the pore.
and E1 and E2 enzymes, but that it catalyzed its own
hypermodification and the modification of a genuineSUMO1 is a small ubiquitin-like protein. In 1996, it was
SUMO1 substrate, Sp100. In these reactions, RanBP2shown that SUMO1 becomes covalently linked to Ran-
showed considerable substrate specificity: a mutationGAP1, the GTPase-activating protein for the RanGTPase
in the physiological attachment residue drastically de-(reviewed in Melchior, 2000). Ran is required for nuclear
creased modification of Sp100, and RanBP2 did nottransport, cell cycle control, mitotic spindle formation,
substantially modify another SUMO1 conjugation target,and postmitotic nuclear assembly. Compartmentaliza-
p53. Two aspects of these findings were particularlytion of Ran’s regulators between the nucleus and cytosol
surprising: first, RanBP2 did not appear to affect theleads to an asymmetry in its nucleotide binding states
conjugation of RanGAP1, even though these proteinsbetween these compartments during interphase and
are typically found in a very tight complex under mostpromotes the directionality of nuclear transport by di-
circumstances. Second, the hypermodification ofrecting the loading and unloading of transport receptors
RanBP2 included the formation of SUMO1 chains. Thisin a manner that is appropriate to each cellular location
was unexpected because SUMO1 has not been pre-(Gorlich and Kutay, 1999). Modification of RanGAP1 by
viously found to polymerize into chains in vivo.SUMO1 promotes its association to RanBP2 (Melchior,
Pichler et al. (2002) demonstrated that free Ubc9 en-2000), a 358 kDa Ran binding protein on the cytosolic
hances the capacity of a RanBP2-Ubc9 complex to cata-face of the nuclear pore (Yokoyama et al., 1995; see
lyze conjugation of Sp100. These results would be con-Figure, panel A).
sistent with the notion that RanBP2 interacts with Ubc9Subsequent investigations revealed that RanGAP1
in a transient fashion, undergoing multiple rounds ofand other proteins become covalently linked to SUMO1
association and dissociation, perhaps coupled to eachin a manner very similar to ubiquitin conjugation (Mel-
conjugation event. Numerous additional questions re-chior, 2000). The SUMO1 pathway utilizes activation (E1)
main regarding the mechanism whereby RanBP2 actsand conjugation (E2) enzymes that show similarity in
as an E3 enzyme. For instance, the IR region of RanBP2both sequence and biochemical mechanism to analo-
does not possess RING finger motifs found in othergous enzymes in the ubiquitin pathway. A flurry of new
SUMO1 E3 enzymes (Hochstrasser, 2001; Yokoyama etreports has demonstrated the existence of SUMO1 li-
al., 1995), nor is it inactivated by treatment with alkylat-gases (E3 enzymes), including the PIAS family of RING
ing agents (Pichler et al., 2002). These facts suggestfinger proteins (reviewed in Hochstrasser, 2001). The
that the biochemical mechanism of RanBP2’s activitysearch for E3 enzymes has now provided a surprising
as an E3 enzyme is likely to be novel, and its investiga-new twist in the tale of SUMO1 at the nuclear pore: in
tion will be of considerable future interest.the January 11th issue of Cell, Pichler et al. show that
What might be the significance of RanBP2’s functionRanBP2 is an E3 enzyme for SUMO1.
as a SUMO1 ligase, and how might this activity be re-When carrying out in vitro assays to examine the up-
lated to the other functions of this large protein? Onetake of tagged SUMO1 into nuclei, Pichler et al. (2002)
intriguing possibility is that RanBP2 couples nuclearnoticed that it accumulated on the cytosolic face of the
translocation with conjugation for a subset of SUMO1nuclear pore. They went on to find that tagged SUMO1
targets (Pichler et al., 2002; see Figure, panel B). It isbecame conjugated to proteins that were at the pore
attractive to speculate that the interaction of import re-under these circumstances. Intrigued by this result, Pil-
ceptors with RanBP2 during the process of protein im-cher et al. investigated the role of RanBP2 in this phe-
port may promote the conjugation of their cargo andnomenon. The RanBP2 protein encodes domains that
can bind to RanGTP and RanGDP, as well as repeats thereby contribute to the specificity of conjugation.
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Possible Roles for RanBP2 in Transport-Coupled SUMO1 Conjugation
(A) Domain structure of RanBP2. Domains implicated in binding to components of the Ran pathway or SUMO1 conjugation machinery are
indicated. For more details, see Yokoyama et al. (1995), Saitoh et al. (1998), Matunis et al. (1998), and Yaseen and Blobel (1999).
(B) Possible model for SUMO1 conjugation coupled to nuclear transport. Import receptor binding to RanBP2 FxFG motifs (step 1) during
import may promote substrate conjugation by RanBP2 (step 2). After translocation through the pore (step 3), the substrate would be released
from its import receptor through the action of RanGTP (step 4). Evidence in yeast suggests that SUMO isopeptidases may reside in the nuclear
pore (Li and Hochstrasser, 2000). Although their function has not yet been established, it is possible that isopeptidases could promote
deconjugation at substrate release.
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